About Index Trending news
Analyze
Pricing
IsoPlexis

IsoPlexis

IsoPlexis

IsoPlexis, a venturebacked Yalespinout company, is developing a diagnostic platform to accelerate immunology research and therapeutic development.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Venture capital
$5,750,000
Employees

Team size

10+
Locations
HQ
Headquarters
$13,500,000 Angel
PE Hub

IsoPlexis Corp snags $13.5 mln Series B